Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Major Bleeding Post-Renal Transplant in Anticoagulated Patients: A Retrospective Cohort Study

Bisan Shweikialrefaee, Joseph Kim, Segun Famure, Jameel Abdulrehman

Blood (2024) 144 (Supplement 1): 5557.

https://doi.org/10.1182/blood-2024-201631

Published: 2024

Journal Articles

HMGA1 Chromatin Regulators Disrupt 3D Genome Architecture and Chromatin Looping to Repress MHC II Genes and Drive Immune Evasion during MPN Progression

Linda Resar, Joseph Kim, Audrey-Ann Supreme, Hyunsung Woo, Bailey West, Mariah C. Antopia, Zanshe Thompson, Karen Reddy, Jung-Hyun Kim, Leslie Cope, Raajit Rampal, Richard Koche, Alison R. Moliterno, Jerry L. Spivak

Blood (2024) 144 (Supplement 1): 756.

https://doi.org/10.1182/blood-2024-211336

Published: 2024

Journal Articles

Findings from a Longitudinal Series of Continuing Education and Quality Improvement Programs in Myelofibrosis

Joseph Kim, Ruben A. Mesa, Linda Gracie-King, Marc David Viens, Victor Ocana, Stephanie Wenick

Blood (2024) 144 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2024-199378

Published: 2024

Journal Articles

A Patient-Centric Registry Dataset Generates Real-World Insights about Cause, Timing, Type, and Impact of Cardiotoxic Adverse Events in Chronic Lymphocytic Leukemia

Hana E. Littleford, Nivita Singh-Bulkan, Melissa Bacchus, MHS, PA-C, Joseph Kim, Richard L. Martin, Alix M.B. Lacoste, Elise Brimble, Conner O'Brien, Larry A. Saltzman, Lee M. Greenberger, Amanda Nottke

Blood (2023) 142 (Supplement 1): 2404.

https://doi.org/10.1182/blood-2023-177734

Published: 2023

Journal Articles

Real-World Patterns of MRD Testing and Impact on Treatment for Chronic Lymphocytic Leukemia Patients

Melissa Bacchus, MHS, PA-C, Nivita Singh-Bulkan, Hana E. Littleford, Joseph Kim, Richard L. Martin, Alix M.B. Lacoste, Elise Brimble, Conner O'Brien, Larry A. Saltzman, Lee M. Greenberger, Amanda Nottke

Blood (2023) 142 (Supplement 1): 6527.

https://doi.org/10.1182/blood-2023-174944

Published: 2023

Journal Articles

HMGA1 Chromatin Regulators Drive Immune Evasion in MPN Progression through Epigenetic Rewiring to Repress Antigen Presentation

Joseph Kim, Audrey-Ann Supreme, Bailey West, Mariah C. Antopia, Karen Reddy, Leslie Cope, Jung-Hyun Kim, Raajit K. Rampal, Richard Koche, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2023) 142 (Supplement 1): 992.

https://doi.org/10.1182/blood-2023-186452

Published: 2023

Journal Articles

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation

Joseph Kim, Jung-Hyun Kim, Leslie Cope, Liping Li, Raajit K Rampal, Richard Koche, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2022) 140 (Supplement 1): 801–802.

https://doi.org/10.1182/blood-2022-166969

Published: 2022

Journal Articles

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

Blood (2022) 139 (18): 2797–2815.

https://doi.org/10.1182/blood.2021013925

Published: 2022

Includes: Supplemental data

Journal Articles

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation and Immune Attack

Joseph Kim, Jung-Hyun Kim, Leslie Cope, Liping Li, Raajit Rampal, Richard Koche, Donna M Williams, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2021) 138 (Supplement 1): 2546.

https://doi.org/10.1182/blood-2021-151139

Published: 2021

Journal Articles

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

Liping Li, Jung-Hyun Kim, Wenyan Lu, Leslie Cope, Donna M Williams, Joseph Kim, Raajit Rampal, Richard Koche, Lingling Xian, Li Luo, Marija Vasiljevic, Daniel R Matson, Zhizhuang Joe Zhao, Ophelia Rogers, Matthew C. Stubbs, Karen Reddy, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2021) 138 (Supplement 1): 625.

https://doi.org/10.1182/blood-2021-144712

Published: 2021

Journal Articles

High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN

Liping Li, MD PhD, Wenyan Lu, PhD, Alison R. Moliterno, MD, Lingling Xian, MD PhD, Joseph Kim, BS, Ophelia Rogers, Jerry L. Spivak, MD, Linda Resar, MD

Blood (2019) 134 (Supplement_1): 1680.

https://doi.org/10.1182/blood-2019-130262

Published: 2019

Journal Articles

Ischemic Pain Testing Demonstrates Hypoxia Dependent Early Pain and Hypoxia Independent Persistent Pain Responses in Adults with Sickle Cell Anemia

Kathleen Vaughan, BA, Joseph Kim, BS, Daniel Lichy, BS, Nathan S Fishman, BA, Amit Khandhadia, BS, You Keun Kim, Stephen Yoon, BS, Niral Sheth, BS, James Ahad, BS, Hans Ackerman, MD, Inna Belfer, MD PhD, Alexander M. Gorbach, PhD, James G. Taylor, MD

Blood (2016) 128 (22): 3657.

https://doi.org/10.1182/blood.V128.22.3657.3657

Published: 2016

Journal Articles

Altered Oxygenation, Vascular and Ischemic Pain Responses in Adults with Sickle Cell Anemia

Nathan S Fishman, BA, Joseph Kim, BS, Daniel Lichy, BS, Kathleen Vaughan, BA, Stephen Yoon, BS, Niral Sheth, BS, James Ahad, BS, Deepika Darbari, MD, Katherine Chadwick, RN, MSN,OCN, Hans Ackerman, MD, Alexander M. Gorbach, PhD, James G. Taylor, MD

Blood (2015) 126 (23): 3399.

https://doi.org/10.1182/blood.V126.23.3399.3399

Published: 2015

Journal Articles

First Selective KIT D816V Inhibitor for Patients with Systemic Mastocytosis

Erica K. Evans, PhD, Brian L. Hodous, PhD, Alexandra Gardino, PhD, Julia Zhu, B.S., Adam Shutes, PhD, Alison Davis, PhD, Joseph Kim, PhD, Kevin Wilson, M.S., Doug Wilson, PhD, Yulian Zhang, PhD, Nancy E. Kohl, PhD, Timothy Guzi, PhD, Christoph Lengauer, PhD

Blood (2014) 124 (21): 3217.

https://doi.org/10.1182/blood.V124.21.3217.3217

Published: 2014

Journal Articles

Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells

Christopher J. Ong, Andrew Ming-Lum, Matt Nodwell, Ali Ghanipour, Lu Yang, David E. Williams, Joseph Kim, Loutfig Demirjian, Pooran Qasimi, Jens Ruschmann, Li-Ping Cao, Kewei Ma, Stephen W. Chung, Vincent Duronio, Raymond J. Andersen, Gerald Krystal, Alice L.-F. Mui

Blood (2007) 110 (6): 1942–1949.

https://doi.org/10.1182/blood-2007-03-079699

Published: 2007

Includes: Supplemental data

NARROW

Major Bleeding Post-Renal Transplant in Anticoagulated Patients: A Retrospective Cohort Study

HMGA1 Chromatin Regulators Disrupt 3D Genome Architecture and Chromatin Looping to Repress MHC II Genes and Drive Immune Evasion during MPN Progression

Findings from a Longitudinal Series of Continuing Education and Quality Improvement Programs in Myelofibrosis

A Patient-Centric Registry Dataset Generates Real-World Insights about Cause, Timing, Type, and Impact of Cardiotoxic Adverse Events in Chronic Lymphocytic Leukemia

Real-World Patterns of MRD Testing and Impact on Treatment for Chronic Lymphocytic Leukemia Patients

HMGA1 Chromatin Regulators Drive Immune Evasion in MPN Progression through Epigenetic Rewiring to Repress Antigen Presentation

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation and Immune Attack

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN

Ischemic Pain Testing Demonstrates Hypoxia Dependent Early Pain and Hypoxia Independent Persistent Pain Responses in Adults with Sickle Cell Anemia

Altered Oxygenation, Vascular and Ischemic Pain Responses in Adults with Sickle Cell Anemia

First Selective KIT D816V Inhibitor for Patients with Systemic Mastocytosis

Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only